Agios Pharmaceuticals
AGIO
$34.34
Share price
-1.89%
Change (1 day)
32.18%
Change (1 year)
Categories
Agios Pharmaceuticals (AGIO) Fails to deliver data
Key failure to deliver metrics for Agios Pharmaceuticals :
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: $0.02 M
- Last 3 months FTD volume: $0.76 M
- Last year FTD volume: $5.37 M
Failures to deliver for Agios Pharmaceuticals (AGIO) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Agios Pharmaceuticals (AGIO) - since 2013
Volume in USD (price x number of shares), data since 2013Agios Pharmaceuticals (AGIO) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.95 M | -83% |
| 2023 | $5.63 M | -47.04% |
| 2022 | $10.64 M | -78.79% |
| 2021 | $50.19 M | 99.19% |
| 2020 | $25.19 M | -38.94% |
| 2019 | $41.27 M | 37.04% |
| 2018 | $30.11 M | -64.73% |
| 2017 | $85.38 M | -15.3% |
| 2016 | $0.10 B | -39.49% |
| 2015 | $0.16 B | 158.36% |
| 2014 | $64.48 M | 918.76% |
| 2013 | $6.32 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $10.32 M | $0.31 B | 🇺🇸 USA |
 Eli Lilly LLY | $56.64 M | $0.12 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $18.31 M | $24.09 M | 🇬🇧 UK |
 Xencor XNCR | $0.15 M | $1.86 M | 🇺🇸 USA |
 Exelixis EXEL | $0.67 M | $5.68 M | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.77 M | $7.27 M | 🇺🇸 USA |